303 related articles for article (PubMed ID: 9361658)
1. Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms.
Marin DB; Green CR; Schmeidler J; Harvey PD; Lawlor BA; Ryan TM; Aryan M; Davis KL; Mohs RC
J Am Geriatr Soc; 1997 Nov; 45(11):1331-8. PubMed ID: 9361658
[TBL] [Abstract][Full Text] [Related]
2. The impact of behavioral impairment of functional ability in Alzheimer's disease.
Green CR; Marin DB; Mohs RC; Schmeidler J; Aryan M; Fine E; Davis KL
Int J Geriatr Psychiatry; 1999 Apr; 14(4):307-16. PubMed ID: 10340193
[TBL] [Abstract][Full Text] [Related]
3. [Noncognitive symptoms in Alzheimer's disease. A study of 150 community-dwelling patients using a questionnaire completed by the caregiver].
Derouesné C; Piquard A; Thibault S; Baudouin-Madec V; Lacomblez L
Rev Neurol (Paris); 2001 Feb; 157(2):162-77. PubMed ID: 11283463
[TBL] [Abstract][Full Text] [Related]
4. The cardinal features of cognitive and noncognitive dysfunction and the differential efficacy of tacrine in Alzheimer's disease patients.
Talwalker S
J Biopharm Stat; 1996 Nov; 6(4):443-56. PubMed ID: 8969979
[TBL] [Abstract][Full Text] [Related]
5. Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults.
Van der Mussele S; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
Int J Geriatr Psychiatry; 2013 Mar; 28(3):265-75. PubMed ID: 22549770
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
7. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease.
Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
J Alzheimers Dis; 2014; 38(2):319-29. PubMed ID: 23963290
[TBL] [Abstract][Full Text] [Related]
8. Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease.
Raskind MA; Sadowsky CH; Sigmund WR; Beitler PJ; Auster SB
Arch Neurol; 1997 Jul; 54(7):836-40. PubMed ID: 9236571
[TBL] [Abstract][Full Text] [Related]
9. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
10. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.
Van der Mussele S; Le Bastard N; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
Aging Ment Health; 2015; 19(3):247-57. PubMed ID: 24962058
[TBL] [Abstract][Full Text] [Related]
11. Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis.
Koppel J; Goldberg TE; Gordon ML; Huey E; Davies P; Keehlisen L; Huet S; Christen E; Greenwald BS
Am J Geriatr Psychiatry; 2012 Nov; 20(11):994-1000. PubMed ID: 22048323
[TBL] [Abstract][Full Text] [Related]
12. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
Harwood DG; Sultzer DL; Wheatley MV
Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
[TBL] [Abstract][Full Text] [Related]
13. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Wattmo C; Wallin ÅK
Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
[TBL] [Abstract][Full Text] [Related]
14. Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment.
Fernández M; Gobartt AL; Balañá M;
BMC Neurol; 2010 Sep; 10():87. PubMed ID: 20920205
[TBL] [Abstract][Full Text] [Related]
15. APOE-related frequency of cognitive and noncognitive symptoms in dementia.
Cacabelos R; Rodríguez B; Carrera C; Caamaño J; Beyer K; Lao JI; Sellers MA
Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):693-706. PubMed ID: 9121226
[TBL] [Abstract][Full Text] [Related]
16. Psychopathological features in Alzheimer's disease: course and relationship with cognitive status.
Holtzer R; Tang MX; Devanand DP; Albert SM; Wegesin DJ; Marder K; Bell K; Albert M; Brandt J; Stern Y
J Am Geriatr Soc; 2003 Jul; 51(7):953-60. PubMed ID: 12834515
[TBL] [Abstract][Full Text] [Related]
17. D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer's disease or mild cognitive impairment.
Lin CH; Yang HT; Lane HY
Pharmacol Biochem Behav; 2019 Oct; 185():172760. PubMed ID: 31422081
[TBL] [Abstract][Full Text] [Related]
18. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease.
Devanand DP
Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S3-8. PubMed ID: 10622673
[TBL] [Abstract][Full Text] [Related]
19. The correlation between cerebral arterial pulsatility and cognitive dysfunction in Alzheimer's disease patients.
Lim JS; Lee JY; Kwon HM; Lee YS
J Neurol Sci; 2017 Feb; 373():285-288. PubMed ID: 28131207
[TBL] [Abstract][Full Text] [Related]
20. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease.
Ihl R; Ferris S; Robert P; Winblad B; Gauthier S; Tennigkeit F
Int J Geriatr Psychiatry; 2012 Jan; 27(1):15-21. PubMed ID: 21384431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
